ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 235 filers reported holding ARGENX SE in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,369,718 | +85.6% | 5,444 | +52.8% | 0.00% | 0.0% |
| Q1 2024 | $1,277,015 | +33.6% | 3,563 | +49.1% | 0.00% | – |
| Q4 2023 | $955,737 | -8.6% | 2,390 | +12.8% | 0.00% | -100.0% |
| Q3 2023 | $1,045,684 | +30.2% | 2,119 | +0.7% | 0.00% | – |
| Q2 2023 | $802,844 | -2.1% | 2,104 | -4.3% | 0.00% | – |
| Q1 2023 | $820,250 | -0.6% | 2,198 | +5.4% | 0.00% | – |
| Q4 2022 | $824,909 | +21.7% | 2,086 | +16.0% | 0.00% | – |
| Q3 2022 | $678,000 | -11.6% | 1,799 | -15.5% | 0.00% | -100.0% |
| Q2 2022 | $767,000 | – | 2,130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 78,138 | $12,543,000 | 7.60% |
| Redmile Group, LLC | 1,153,232 | $185,117,000 | 4.43% |
| Avoro Capital Advisors LLC | 936,500 | $150,327,000 | 4.41% |
| MPM BioImpact LLC | 71,700 | $11,509,000 | 4.08% |
| AWM Investment Company, Inc. | 95,000 | $15,249,000 | 2.98% |
| EcoR1 Capital, LLC | 202,117 | $32,444,000 | 2.92% |
| INDUS CAPITAL PARTNERS, LLC | 79,095 | $12,696,000 | 2.49% |
| Bellevue Group AG | 967,989 | $156,070,000 | 2.47% |
| DCF Advisers, LLC | 22,000 | $3,531,000 | 2.24% |
| Dorsey Wright & Associates | 41,416 | $6,648,000 | 2.20% |